학술논문
Modified tetrahalogenated benzimidazoles with CK2 inhibitory activity are active against human prostate cancer cells LNCaP in vitro
Document Type
Article
Author
Source
In Bioorganic & Medicinal Chemistry 15 July 2012 20(14):4390-4396
Subject
Language
ISSN
0968-0896